Prospective Randomized Trial of Monocryl Versus Nylon Suture Closure in Carpal Tunnel Surgery

Objectives:

The aim of this study is to determine if there is a significant difference in provider-assessed and patient-assessed outcomes using subcuticular Monocryl vs traditional Nylon sutures for wound closure following open carpal tunnel decompression surgery.

Null hypothesis: There is no significant difference in provider-assessed or patient-assessed outcomes, as measured by the Patient and Observer Scar Assessment Scale (POSAS), between subcuticular Monocryl and traditional nylon wound closure methods after open carpal tunnel surgery.

Alternative hypothesis: Using a running subcuticular Monocryl suture for wound closure following open carpal tunnel release will result in significantly improved POSAS scores in comparison to traditional nylon wound closure

Background:

Open carpal tunnel decompression surgery is a common procedure, but controversy still exists regarding what wound closure method optimizes wound healing, cosmetic and patient satisfaction outcomes.

Research concerning the superiority of absorbable or non-absorbable sutures in the setting of wound closure for carpal tunnel decompression surgery is largely inconclusive, due to high risk of bias in previous comparison trials. Although some studies suggest that absorbable sutures confer a higher risk of infection, other studies suggest that absorbable sutures confer superior pain reduction, and still others suggest use of non-absorbable sutures due to reduced cost, both with respect to materials and by avoiding an additional clinician visit for suture removal.

A rigorous randomized trial of absorbable versus non-absorbable sutures as wound closure methods following minor elective hand surgery procedures is indicated, to compare wound healing, cosmesis, patient-reported outcome measures, as well as cost for each method.

Study Timelines:

Participants will be enrolled either at their pre-operative clinic visit or on the day of their surgery in the preoperative holding area (PHA). They will receive 2 follow-up appointments at 10-14 days and 6 weeks, after the surgery. Patients are considered enrolled in the study until after their 6-week appointment.

Power Analysis:

The power analysis will use alpha = 0.05 and beta (power) = 0.8. Using the Fleisher et al. paper, the mean Observer Scar Assessment Scale (OSAS) was 12 ± 3 for the suture group (p < 0.01), and the mean for the staple group was 13. If the investigators expect to see a similar difference between absorbable versus non-absorbable sutures, based on a two-sample t-test they would have to enroll 141 patients in each arm to have an 80% chance of seeing a difference at least this large, if there truly is one.

It is anticipated that a small percentage of patients will drop out of the study prior to completing their study endpoints. If the study allows for an approximate 15% dropout rate, then the investigators will plan to enroll 325 patients to ensure appropriate power. Looking at the surgeon numbers, each of the primary surgeons perform between 50-90 carpal tunnel surgeries per year. Therefore, the investigators estimate a 2.5 year enrollment period, followed by a six-month data review period.

Study Endpoints:

The primary study endpoint for subjects is a completed POSAS surveys at 6 weeks after their surgery.

There are no safety endpoints, as the study consists of a single intervention and both closure methods are well described and well tolerated (non-experimental).

Procedures Involved:

Patients will be identified by the operating surgeon (Dr. Szabo, Dr. Bayne or Dr. Allen) and enrolled either at their pre-operative clinic visit or in the preoperative holding area on the day of their surgery by either the operating surgeon or research personnel. After signing consent, the consenting researcher will use a digital Randomizer application ("Randomizer", available on all smart phones) to assign the individual to either Subcuticular Monocryl wound closure or traditional nylon wound closure. After being randomized, the study arm will be noted at the top of their consents and the consent scanned into the patient's electronic medical record. The hard copy consents will be stored securely as outlined below.

Patients will undergo surgery with the assigned wound closure. At each follow-up appointment (at approximately 2 and 6 weeks), patients and their operating physician will be given the POSAS questionnaire. In addition, patients will be asked the following question: "How satisfied are you with the results of the carpal tunnel surgery and recovery?" Assessed using a 5-point scale: completely satisfied (1 point), very satisfied (2 point), rather satisfied (3 point), dissatisfied (4 point), and completely dissatisfied (5 point).

Outcomes of the POSAS and satisfaction question will be complied into a research database and the de-identified data will be analyzed for significant differences between Subcuticular Monocryl and traditional nylon methods of wound closure.

During the data analysis phase of the study, a cost comparison will be performed, examining the cost of materials for each arm (assuming one suture packet used per patient). The investigators will also consider the cost differential in follow up visits, if patients closed with absorbable Monocryl sutures could be limited to one 6-week follow up visit, versus the nylon closure patients which would need an additional early visit for suture removal. No protected health information will need to be examined for this analysis.

Inclusion criteria

• Patients at the University of California, Davis Health Center who are scheduled to undergo surgery for carpal tunnel release will be screened for eligibility for this study.
• Patients who do not speak English will be included in this study, and will be provided with appropriate translators at all communication points.

Exclusion criteria

• Patients who are not able to follow up at the 2 and 6 week postoperative time points.
• Patients who have known skin sensitivity to tape or absorbable suture.
• Those who are unable to give informed consent, individuals who are not yet adults (18 years or older), pregnant women, and prisoners will be excluded from this study.